Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Race, Ethnicity, and Language Disparities in Alcohol and Drug Screening and Medication Treatment.

JAMA network open·2026
Same author

Contingency Management for the Treatment of Stimulant Use Disorder.

JAMA internal medicine·2026
Same author

Cervical Cancer Screening among Older Latina Migrant and Seasonal Farmworkers in a Network of Community Health Centers.

Ethnicity & disease·2026
Same author

Polymer solutions under steady solvent flow between two semipermeable interfaces.

Macromolecules·2026
Same author

Early health technology assessment of a primary care tool for the diagnosis and management of headaches in Alberta, Canada.

International journal of technology assessment in health care·2026
Same author

High-Throughput In Vivo Subcellular Analysis of Gold Nanoparticles for Tumor Mitochondrial Targeting.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Zein-Ceria Hybrid Microparticles Enable Long-Term ROS-Scavenging Oxygenation for Osteogenic Microtissues Engineering.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Toward Practical Solid-State Lithium Batteries With High-Nickel Cathodes: An Interface-Centered Perspective.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

A Planarity-Hindrance Co-Balance Strategy to Develop Antiparallel H-Aggregates With Minimal Absorbance Blueshift for Type I Photodynamic Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Exceptional Rare-Earth Half-Heusler Thermoelectrics With Sublattice Softening.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Co-Assembled Hybrid Interlayer Engineering for Enhanced Upper Interface Stability in Inverted Perovskite Solar Cells.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Impact-Resistant Hydrogels Via Quaternary Ammonium-Regulated Networks.

Advanced materials (Deerfield Beach, Fla.)·2026
See all related articles

Related Experiment Video

Updated: Nov 9, 2025

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

30.9K

Materials for Improving Immune Cell Transfection.

Arun R K Kumar1,2, Yufeng Shou1, Brian Chan1

  • 1Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.

Advanced Materials (Deerfield Beach, Fla.)
|April 16, 2021
PubMed
Summary
This summary is machine-generated.

Developing novel transfection methods is crucial for advancing chimeric antigen receptor T cell (CAR-T) therapy manufacturing. Emerging techniques offer higher efficiency and safety for engineering immune cells for cancer treatment.

Keywords:
chimeric antigen receptor T-cell therapyhigh-aspect-ratio nanostructuresmicrofluidicsnanoparticlestransfection techniques

More Related Videos

Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
10:15

Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation

Published on: April 13, 2017

8.1K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.0K

Related Experiment Videos

Last Updated: Nov 9, 2025

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

30.9K
Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
10:15

Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation

Published on: April 13, 2017

8.1K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.0K

Area of Science:

  • Biotechnology
  • Immunotherapy
  • Cell Engineering

Background:

  • Chimeric antigen receptor T cell (CAR-T) therapy shows significant potential for treating cancers.
  • Current methods for engineering primary immune cells for CAR-T therapy face challenges in efficiency and safety.
  • Viral vectors and bulk electroporation have limitations, including low efficiency, transgene integration, and biological disruption.

Purpose of the Study:

  • To review traditional and emerging transfection techniques for immune cell engineering.
  • To discuss the strengths and limitations of various transfection materials and their commercial development.
  • To recommend in vitro and in vivo assays for characterizing transfection methods and guide clinical adoption.

Main Methods:

  • Review of existing literature on viral and non-viral transfection methods.
  • Analysis of microfluidics, nanoparticles, and nanostructures for immune cell engineering.
  • Discussion of commercialization aspects of transfection technologies.

Main Results:

  • Emerging techniques like microfluidics, nanoparticles, and nanostructures offer improved efficiency and throughput for cell transfection.
  • These novel methods can overcome limitations associated with traditional viral vectors and electroporation.
  • A framework for assay-based characterization of transfection techniques is proposed.

Conclusions:

  • Novel transfection materials are essential to meet the growing demand for clinical CAR-T cell manufacturing.
  • Advancements in transfection technology are key to improving the safety and efficacy of CAR-T therapies.
  • Standardized characterization and clinical adoption of new methods are needed to accelerate therapeutic development.